4//SEC Filing
Lee Sung 4
Accession 0001209191-23-021548
CIK 0001706431other
Filed
Mar 28, 8:00 PM ET
Accepted
Mar 29, 5:49 PM ET
Size
7.2 KB
Accession
0001209191-23-021548
Insider Transaction Report
Form 4
Lee Sung
Chief Financial Officer
Transactions
- Award
Common Stock
2023-03-27+66,500→ 66,500 total - Award
Stock Option (Right to Buy)
2023-03-27+133,000→ 133,000 totalExercise: $23.01Exp: 2033-03-26→ Common Stock (133,000 underlying)
Footnotes (2)
- [F1]Acquisition of restricted stock units pursuant to the Issuer's Equity Incentive Plan.
- [F2]25% of the shares subject to the stock option vest and become exercisable on March 27, 2024, and the remainder vest in 36 equal monthly installments thereafter.
Documents
Issuer
Vir Biotechnology, Inc.
CIK 0001706431
Entity typeother
Related Parties
1- filerCIK 0001793200
Filing Metadata
- Form type
- 4
- Filed
- Mar 28, 8:00 PM ET
- Accepted
- Mar 29, 5:49 PM ET
- Size
- 7.2 KB